Abstract
Cough is an important symptom of asthma. The objective assessment of chronic cough has been enhanced by the development of ambulatory cough monitoring systems. Mepolizumab has been demonstrated to reduce exacerbations in eosinophilic asthmatics long-term. We evaluate the utility of objective cough count as an outcome measure in severe eosinophilic asthma treated with mepolizumab. Consecutive, consenting patients initiated on treatment with mepolizumab had a 24-h cough count recorded at baseline; this was repeated at 1, 3 and 6 months. Asthma control questionnaire (ACQ) scores and exacerbation frequency were also recorded. The mean 24-h cough count in 11 subjects (8 females, mean age 53.6 years) was 172.4 at baseline; at 1, 3 and 6 months following initiation of treatment this decreased to 101.4, 92 and 70.8, respectively (p < 0.02). Significant improvements were also observed in mean ACQ score (3–1.6, p < 0.01) and exacerbation frequency (5.5 per year – 1.3, p < 0.01). Objective cough measurement could be used as an early, precise and clinically relevant endpoint in assessing response to asthma therapy.
This is a preview of subscription content, log in via an institution to check access.
References
McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ (2017 ) Diagnosis and management of asthma in adults: a review. JAMA 318(3):279–290
Satia I, Badri H, Woodhead M, O’byrne PM, Fowler SJ, Smith JA (2017) The interaction between bronchoconstriction and cough in asthma. Thorax 72(12):1144–1146
Osman LM, McKenzie L, Cairns J, Friend JA, Godden DJ, Legge JS, Douglas JG (2001) Patient weighting of importance of asthma symptoms. Thorax 56(2):138–142
Asthma UK (2018) Asthma facts and statistics. Retrieved June 29, 2020, from https://www.asthma.org.uk/about/media/facts-and-statistics/
Levy M, Andrews R, Buckingham R, Evans H, Francis C, Houston R, Lowe D, Nasser S, Paton J, Puri N, Stewart K. Why asthma still kills: the National Review of Asthma Deaths (NRAD). Royal College of Physcians. http://eprints.uwe.ac.uk/23453. Accessed 6 May 2014
Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J, Beasley R (2016 ) Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 47(2):410–419
Faruqi S, Kastelik JA (2011) The clinical evaluation of chronic cough. Curr Respir Med Rev 7(1):14–20
Lai K, Chen R, Peng W, Zhan W (2017) Non-asthmatic eosinophilic bronchitis and its relationship with asthma. Pulm Pharmacol Ther 1(47):66–71
Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID (2009 ) Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 360(10):973–984
Juniper EF, O’byrne PM, Guyatt GH, Ferrie PJ, King DR (1999) Development and validation of a questionnaire to measure asthma control. Eur Respir J 14(4):902–907
Faruqi S, Thompson R, Wright C, Sheedy W, Morice AH (2011 ) Quantifying chronic cough: objective versus subjective measurements. Respirology 16(2):314–320
Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP (2014 ) International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43(2):343–373
Heaney LG (2017 ) Cough and severe asthma. Pulm Pharmacol Ther 47:72–76
Marsden PA, Satia I, Ibrahim B, Woodcock A, Yates L, Donnelly I, Jolly L, Thomson NC, Fowler SJ, Smith JA (2016 ) Objective cough frequency, airway inflammation, and disease control in asthma. Chest 149(6):1460–1466
Kanemitsu Y, Fukumitsu K, Kurokawa R, Takeda N, Suzuki M, Yap J, Nishiyama H, Tajiri T, Fukuda S, Uemura T, Ohkubo H (2020 ) Increased capsaicin sensitivity in patients with severe asthma is associated with worse clinical outcome. Am J Respir Crit Care Med 201(9):1068–1077
Satia I, Watson R, Scime T, Dockry RJ, Sen S, Ford JW, Mitchell PD, Fowler SJ, Gauvreau GM, O'Byrne PM, Smith JA (2019 ) Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma. J Allergy Clin Immunol 144(3):788–795
Faruqi S, Shiferaw D, Morice AH (2016) Effect of ivacaftor on objective and subjective measures of cough in patients with cystic fibrosis. Open Respir Med J 10:105
Faruqi S, Morice AH (2011) Epidemiology and pathophysiology of chronic cough. Curr Respir Med Rev 7(1):5–9
Song WJ, Chang YS, Faruqi S, Kim JY, Kang MG, Kim S et al (2015) The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 45:1479–1481
Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Ribas CD, Boon MH, Kantar A, Lai K, McGarvey L, Rigau D (2019) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. https://doi.org/10.1183/13993003.01136-2019
Polley L, Yaman N, Heaney L, Cardwell C, Murtagh E, Ramsey J, MacMahon J, Costello RW, McGarvey L (2008 ) Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest 134(2):295–302
Faruqi S, Zhou S, Thompson J, Robinson T, Watkins K, Cummings H, Jackson N, Prakash A, Crooks M (2019 ) Suppression of FENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice? ERJ Open Res 5(4):00123–2019
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Faruqi, S., Sykes, D.L., Crooks, M.G. et al. Objective Assessment of Cough: An Early Marker of Response to Biological Therapies in Asthma?. Lung 198, 767–770 (2020). https://doi.org/10.1007/s00408-020-00391-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-020-00391-w